Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study

NCT00885417 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00885417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00885417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
December 31, 2010
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h. pylori infection